DekaBank Deutsche Girozentrale - INTERCEPT PHARMACEUTICALS IN ownership

INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 145 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is 1.70 and the average weighting 0.0%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of INTERCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2021$167,000
-27.4%
11,0900.0%0.00%
-100.0%
Q2 2021$230,000
-7.3%
11,0900.0%0.00%0.0%
Q1 2021$248,000
-8.1%
11,0900.0%0.00%0.0%
Q4 2020$270,000
-40.9%
11,0900.0%0.00%
-50.0%
Q3 2020$457,000
-49.9%
11,090
-22.1%
0.00%
-66.7%
Q3 2019$913,000
-60.9%
14,240
-51.5%
0.01%
-50.0%
Q2 2019$2,333,000
+165.7%
29,380
+267.7%
0.01%
+140.0%
Q1 2019$878,000
-35.8%
7,990
-45.6%
0.01%
-44.4%
Q4 2018$1,367,000
+55.7%
14,690
+83.9%
0.01%
+80.0%
Q3 2018$878,000
+34.3%
7,990
-2.4%
0.01%
+25.0%
Q2 2018$654,000
+32.7%
8,1900.0%0.00%
+33.3%
Q1 2018$493,000
-44.3%
8,190
-2.4%
0.00%
-57.1%
Q4 2017$885,0000.0%8,3900.0%0.01%0.0%
Q3 2017$885,000
-14.1%
8,3900.0%0.01%
-12.5%
Q2 2017$1,030,000
+8.8%
8,3900.0%0.01%
-11.1%
Q1 2017$947,000
+222.1%
8,390
+223.9%
0.01%
+200.0%
Q4 2016$294,000
-23.2%
2,590
+8.4%
0.00%
-25.0%
Q3 2016$383,000
+7.0%
2,3900.0%0.00%0.0%
Q2 2016$358,000
-72.7%
2,390
-77.2%
0.00%
-73.3%
Q1 2016$1,309,000
-29.1%
10,470
-14.9%
0.02%
-28.6%
Q4 2015$1,847,000
-8.1%
12,310
+1.7%
0.02%
-16.0%
Q3 2015$2,009,000
-23.7%
12,110
+11.0%
0.02%
-19.4%
Q2 2015$2,633,000
-11.2%
10,910
+3.8%
0.03%
-16.2%
Q1 2015$2,964,00010,5100.04%
Other shareholders
INTERCEPT PHARMACEUTICALS IN shareholders Q3 2021
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 185,781$4,611,56512.16%
Samsara BioCapital, LLC 640,688$11,878,3563.64%
ALPINE ASSOCIATES MANAGEMENT INC. 2,203,295$40,849,0892.14%
Versor Investments LP 378,480$7,017,0191.42%
Magnetar Financial LLC 2,407,209$44,629,6551.14%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,077,893$38,524,1360.85%
Fort Baker Capital Management LP 430,600$7,983,3240.74%
EHP Funds Inc. 84,210$1,561,2530.73%
Terrapin Asset Management, LLC 30,000$556,2000.63%
AQR Arbitrage LLC 734,970$13,626,3440.61%
View complete list of INTERCEPT PHARMACEUTICALS IN shareholders